Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03860792 · ClinicalTrials.gov registry record · NA

Therapeutic Diets in Alzheimer's Disease

A NA study of Alzheimer Disease, sponsored by University of Kansas Medical Center.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT03860792 is a NA study of Alzheimer Disease that has completed, run by University of Kansas Medical Center. The registered enrollment target is 84 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03860792, a NA study of Alzheimer Disease, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

By doing this study, researchers hope to learn how the ketogenic and Therapeutic Lifestyles Changes diets affect cognition in patients with Alzheimer's disease.

Conditions Studied

Interventions

  • BEHAVIORAL Ketogenic Diet
  • BEHAVIORAL Therapeutic Lifestyles Changes Diet

Study Locations (1)

Kansas

  • Clinical and Translational Science Unit - Fairway

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2019-10-15
Est. Completion 2025-06-20
Phase NA

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT03860792

The ClinicalTrials.gov registry entry for NCT03860792 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (97% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Ketogenic Diet is the first listed.

NCT03860792 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT03860792 about?

NCT03860792 is a clinical study titled "Therapeutic Diets in Alzheimer's Disease". By doing this study, researchers hope to learn how the ketogenic and Therapeutic Lifestyles Changes diets affect cognition in patients with Alzheimer's disease.

What is the current status of trial NCT03860792?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2019-10-15. Estimated completion is 2025-06-20.

What conditions does trial NCT03860792 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT03860792?

The interventions under investigation include: Ketogenic Diet (BEHAVIORAL), Therapeutic Lifestyles Changes Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT03860792?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03860792 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.